Effect of montelukast for treatment of asthma in cigarette smokers David Price, MD, Todor A. Popov, MD, Leif Bjermer, MD, Susan Lu, PharmD, Romana Petrovic, MS, Kristel Vandormael, MS, Anish Mehta, BA, Jolanta D. Strus, MD, Peter G. Polos, MD, George Philip, MD Journal of Allergy and Clinical Immunology Volume 131, Issue 3, Pages 763-771.e6 (March 2013) DOI: 10.1016/j.jaci.2012.12.673 Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Fig 1 CONSORT diagram showing patient enrollment, randomization, discontinuation, completion, and inclusion of patients in analyses. FAS, Full analysis set. Journal of Allergy and Clinical Immunology 2013 131, 763-771.e6DOI: (10.1016/j.jaci.2012.12.673) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Fig 2 Distribution of percentage of days with asthma control by increments of 5%. Journal of Allergy and Clinical Immunology 2013 131, 763-771.e6DOI: (10.1016/j.jaci.2012.12.673) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Fig 3 Components of primary end point: percentage of days with asthma control during treatment. Journal of Allergy and Clinical Immunology 2013 131, 763-771.e6DOI: (10.1016/j.jaci.2012.12.673) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Fig 4 Primary and secondary endpoints over time. A, Percentage of asthma-control days (primary endpoint). B, Change from baseline in daytime asthma symptom score (0 to 6 scale). C, Change from baseline in morning peak expiratory flow (L/min). Journal of Allergy and Clinical Immunology 2013 131, 763-771.e6DOI: (10.1016/j.jaci.2012.12.673) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Fig 5 Smoothed spline plot of percentage of days with asthma control by treatment group versus smoking history (in pack years; A) and FEV1 percent predicted at baseline (B). Journal of Allergy and Clinical Immunology 2013 131, 763-771.e6DOI: (10.1016/j.jaci.2012.12.673) Copyright © 2013 American Academy of Allergy, Asthma & Immunology Terms and Conditions